ÅǸ޴º
Á¦¸ñ | Chon HJ, and C Kim. REACH-2: first biomarker-based anti-angiogenic therapy in patients with advanced hepatocellular carcinoma. Chinese Clinical Oncology 2020 (first author) | µî·ÏÀÏ | 20200923 | ´Ù¿î·Îµå | |
---|---|---|---|---|---|
Chon HJ, and C Kim. REACH-2: first biomarker-based anti-angiogenic therapy in patients with advanced hepatocellular carcinoma. Chinese Clinical Oncology 2020 (first author)
|
Copyright ¨Ï chamc, All rights reserved.